Yongbin Liu
- Houston Methodist Research Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #27,660
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 78843694Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$654.6K
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#27,660
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Yongbin Liu as a PI. Multi-PI records show the full award amount for context.
- 1R21CA302974-01A1R21Contact PIEnhancing Cancer Immunotherapy for Refractory High-Grade Serous Ovarian Cancer with Novel Platinum Nanotherapeutics$415.3Kaward amount
- 5R21AI187979-02R21Co-investigatorDevelopment of a stable mRNA prophylactic vaccine against SARS-CoV-2 omicron variant$239.3Kaward amount
Award organization
Organizations that administered FY2026 awards listing Yongbin Liu as a PI.
FY2026 award administered by Houston Methodist Research Institute (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardHouston Methodist Research Institute
- 2026$500K Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Yongbin Liu.